HCPCS Level IIdrugActive
J9063
Inj, elahere, 1 mg
BETOS: O1D
Effective: 2023-07-01
Description
Injection, mirvetuximab soravtansine-gynx, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Elahere
Manufacturer
ImmunoGen, Inc.
HCPCS Dosage
1 MG
Billing Units
100.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.